Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyaike, J
Right arrow Articles by Tsuji, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyaike, J
Right arrow Articles by Tsuji, T
Gut 2002;51:591-596
© 2002 by Gut


LIVER DISEASE

Regulation of circulating immune complexes by complement receptor type 1 on erythrocytes in chronic viral liver diseases

J Miyaike1, Y Iwasaki1, A Takahashi1, H Shimomura1, H Taniguchi1, N Koide2, K Matsuura3, T Ogura3, K Tobe3, T Tsuji1

1 First Department of Internal Medicine, Okayama University Medical School, Okayama, Japan
2 Department of Laboratory Medicine, Okayama University Medical School, Okayama, Japan
3 Health and Medical Centre, Okayama University, Okayama, Japan

Correspondence to:
Correspondence to:
Dr Y Iwasaki, First Department of Internal Medicine, Okayama University Medical School, 2-5-1, Shikata-cho, Okayama 700-8558, Japan;
yiwasaki{at}cc.okayama-u.ac.jp


ABSTRACT
Background and aim: Complement receptor type 1 (CR1) is a transmembrane protein, and human erythrocyte CR1 (E-CR1) is involved in the transport of circulating immune complexes (IC) from the circulation to the reticuloendothelial system, including the liver and spleen. In chronic viral hepatitis, increased levels of IC containing viral particles and an association with various extrahepatic manifestations have been reported. However, regulatory mechanisms for IC levels are not fully understood.

Patients/subjects and methods: We analysed IC, E-CR1, and quantitative polymorphism of the CR1 gene in 149 patients with chronic viral liver diseases and in 64 normal blood donors using an enzyme linked immunosorbent assay, radioimmunoassay, and polymerase chain reaction-restriction fragment length polymorphism, respectively. We also analysed the effect of CR1 gene polymorphism on IC binding to E-CR1 using molecular methods.

Results: E-CR1 levels in patients with chronic hepatitis and chronic viral liver diseases as a whole correlated inversely with increased levels of IC. Moreover, significantly high levels of IC were observed in patients with chronic hepatitis C (CH-C) who were homozygous for the E-CR1 low density allele. We also found low levels of E-CR1 in liver cirrhosis and CH-C but not in CH-B. Low levels of E-CR1 in CH-C were observed, even after considering the polymorphism of the CR1 gene. Finally, we demonstrated CR1 gene polymorphism dependent binding of hepatitis virus containing IC.

Conclusions: Our results emphasise the important role of E-CR1 in clearance of IC from the circulation and the acquired, rather than inherited, decrease in E-CR1 in chronic viral liver diseases, especially of type C.


Keywords: complement receptor type 1; erythrocytes; immune complex; chronic hepatitis; liver cirrhosis

Abbreviations: AIDS, acquired immunodeficiency syndrome; CH-B, chronic hepatitis B; CH-C, chronic hepatitis C; controls, normal blood donors; CR1, complement receptor type 1; CR1/E, mean number of CR1 per erythrocyte; E-CR1, erythrocyte CR1; HBV, hepatitis B virus; HCV, hepatitis C virus; HH, individuals homozygous for the CR1 high density allele; HL, individuals heterozygous for the CR1 gene polymorphism; IC, immune complex; LC-B, liver cirrhosis B; LC-C, liver cirrhosis C; LL, individuals homozygous for the CR1 low density allele; PBS, phosphate buffered saline; PCR-RFLP, polymerase chain reaction-restriction fragment length polymorphism; SLE, systemic lupus erythematosus




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Zorzetto, I. Ferrarotti, R. Trisolini, L. L. Agli, R. Scabini, M. Novo, A. De Silvestri, M. Patelli, M. Martinetti, M. Cuccia, et al.
Complement Receptor 1 Gene Polymorphisms Are Associated with Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 330 - 334.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 BMJ Publishing Group Ltd & British Society of Gastroenterology